Table 2 Patient characteristics and regular medications
From: Creating and evaluating the score to assess overdose: the OD score
Overall n=262 | Overdose n=118 | Other patients n=144 | |
|---|---|---|---|
A. Patient characteristics | |||
Age (mean±SD) | 52.9±22.9 | 39.5±18.1 | 63.9±20.5 |
Sex (n: Male/Female) | 113/149 | 22/96 | 91/53 |
History of psychiatric consultation (n;%: with) | 120; 45.8 | 101; 85.6 | 19; 13.2 |
Recent experience of mental anxiety (n;%: with) | 124; 47.3 | 115; 97.5 | 9; 6.3 |
The scenario at the location of the patient’s discovery (n;%: collapsed in the room) | 254; 96.9 | 118; 100 | 136; 94.4 |
Alcohol consumption (n;%: with) | 49; 18.7 | 33; 28.0 | 16; 11.1 |
Hospitalization days (mean±SD) | 13±22.7 | 5±10.9 | 19±27.6 |
COVID-19 (n;%: positive) | 9; 3.4 | 2; 1.7 | 7; 4.9 |
B. Regular medications | |||
Benzodiazepines (n; %) | 70; 59.3 | 23; 16.0 | |
Antipsychotics (n; %) | 44; 37.3 | 12; 8.3 | |
Antidepressants (n; %) | 41; 34.7 | 9; 6.3 | |
Mood stabilizers (n; %) | 17; 14.4 | 6; 4.2 | |
Cardiovascular drugs (n; %) | 15; 12.7 | 56; 38.9 | |
Antidiabetic drugs (n; %) | 8; 6.8 | 26; 18.1 | |
Respiratory drugs (n; %) | 6; 5.1 | 12; 8.3 | |
OTC drugs (n; %) | 0; 0 | 2; 1.4 |